英文原著

2024年

1. Sofue T, Matsuzawa R, Nishiwaki H, Tsuchida Y, Kosaki K, Hoshino J, Narita I, Yamagata K. A survey on the current situation of exercise guidance during hemodialysis after the approval of insurance claim: A nationwide questionnaire survey in Japan. Sci Rep. 2024[In press]
2. Imaizumi T, Hasegawa T, Kosugi T, Nishiwaki H, Honda H, Tsuruya K, Ito Y, Kuragano T. Management of Anemia and Prognosis in Patients undergoing Maintenance Peritoneal Dialysis: Analysis of JRDR data. Perit Dial Int 2024[In press]
3. Nishiwaki H, Suzuki T, Abe Y, Hasegawa T, Levack WMM, Noma H, Ota E. Erythropoiesis‐stimulating agents for preventing acute kidney injury (review). Cochrane Database of Systematic Reviews 2024 [In press]
4. Ikeda T, Tashiro N, Hasegawa T, Nishiwaki H, Ohtsuka H, Matoba M, Noma H, Ota E. Protein or branched-chain amino acid intake at breakfast for muscle mass gain in older persons: A protocol for systematic review and meta-analysis. Medicine: Case Reports and Study Protocols 5(1):p e00306, January 2024.
5. Sasaki S, Shimizu S, Nakaya I, Miyaoka Y, Koizumi M, Nishiwaki H, Sofue T, Ishimoto T, Kurita N, Wada T. Preference for anti-phospholipase A2 receptor antibody assay in patients with suspected membranous nephropathy: a survey study on medical practice after publication of Japanese Guidelines for Nephrotic Syndrome 2020. Clin Exp Nephrol. 2024 [Epub ahead]
6. Ohtsuka H, Tashiro N, Hasegawa T, Nishiwaki H, Ikeda T, Matoba M, Noma H, Ota E, Levack W.M.M. Multidisciplinary rehabilitation for Parkinson’s disease.(Protocol) Cochrane Database of Systematic Reviews, 2024, 2024(2), CD015742.
7. Oikawa M, Nishiwaki H, Hasegawa T, Sasaki S, Yazawa M, Miyasato H, Saka Y, Shimizu H, Fujita Y, Murakami M, Uchida D, Kawarazaki H, Omiya S, Sasai F, Koiwa F. The association between high-dose allopurinol and erythropoietin hyporesponsiveness in advanced chronic kidney disease. JOINT-KD study. Nephron 2024 [Epub ahead]
8. Miyaoka Y, Kurita N, Sofue T, Nishiwaki H, Koizumi M, Shimizu S, Sasaki S, Ishimoto T, Wada T. Practice patterns of rituximab for primary membranous nephropathy 2021 in Japan: a web-based survey of board-certified nephrologists. Clin Exp Nephrol. 2024 Mar;28(3):217-224.B4

2023年

1. Koiwa F, Yu Sato, Ohara M, Nakanishi K, Fukagawa M, Akizawa T. Long-term safety and decrease of pill burden by tenapanor therapy: a phase 3 open-label study in hemodialysis patients with hyperphosphatemia. Scientific Reports 13: 19100, 2023
2. Wada T, Shimizu S, Koizumi M, Sofue T, Nishiwaki H, Sasaki S, Nakaya I, Oe Y, Ishimoto T, Furuichi K, Okada H, Kurita N. Japanese clinical practice patterns of primary nephrotic syndrome 2021: a web-based questionnaire survey of certified nephrologists. Clin Exp Nephrol. 2023 [Epub ahead]
3. Suzuki T, Nishiwaki H, Watanabe Y, Abe Y, Noma H, Ota E, Honda H, Hasegawa T. The discontinuation of the renin angiotensin system inhibitors and its outcomes: a systematic review and meta-analysis- a study protocol. BMJ Open. 2023. 13(5): e070345.
4. Saito T, Mizobuchi M, Kato T, Ogata H, Koiwa F, Honda H. Fibroblast Growth Factor 23 Exacerbates Cardiac Fibrosis in Deoxycorticosterone Acetate-Salt Mice With Hypertension. Lab Invest 103, 2023 (100003)
5. Shimizu S, Niihata K, Nishiwaki H, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N; Japan Nephrotic Syndrome Cohort Study Group. Initiation of renin-angiotensin system inhibitors and first complete remission in patients with primary nephrotic syndrome: a nationwide cohort study. Clin Exp Nephrol. 2023. 27(5):480-489.
6. Miyauchi T, Nishiwaki H, Mizukami A, Yazawa M. Hyponatremia and mortality in patients undergoing maintenance hemodialysis: systematic review and meta-analysis. Seminar in Dialysis. 2023 [Epub ahead]
7. Ueda H, Tran QTH, Tran LNT, Higasa K, Ikeda Y, Kondo N, Hashiyada M, Sato C, Sato Y, Ashida A, Nishio S, Iwata Y, Iida H, Matsuoka D, Hidaka Y, Fukui K, Itami S, Kawashita N, Sugimoto K, Nozu K, Hattori M, Tsukaguchi H. Characterization of cytoskeletal and structural effects of INF2 variants causing glomerulopathy and neuropathy. Sci Rep. 2023 Jul 25;13(1):12003.
8. Shigematsu T, Koiwa F, Isaka Y, Fukagawa M, Hagita K, Watanabe Y, Honda D, Akizawa T. Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism. A Randomized Placebo-Controlled Trial. Clin J Am Soc Nephrol. 2023
9. Tashiro N, Hasegawa T, Nishiwaki H, Ikeda T, Noma H, Levack W, Ota E. Clinical utility of diaphragmatic ultrasonography for mechanical ventilator weaning in adults: A study protocol for systematic review and meta-analysis. Health Sci Rep. 2023 Jul 13;6(7):e1378.
10. Niihata K, Nishiwaki H, Kinoshita M, Kurosawa K, Sakuramachi Y, Matsunaga S, Okamura S, Tsujii S, Hayashino Y, Kurita N; Diabetes Distress and Care Registry at Tenri Study Group. Association between urinary C-megalin levels and progressive kidney dysfunction: a cohort study based on the diabetes distress and care registry at Tenri (DDCRT 24). Acta Diabetol. 2023
11. Okamura S, Niihata K, Nishiwaki H, Tsujii S, Ishii H, Hayashino Y, Kurita N; Diabetes Distress and Care Registry at Tenri Study Group. Association between physical activity and kidney function decline in patients with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT 11].  J Nephrol. 2023 [Research Letter]

2022年

1. Nishiwaki H, Niihata K, Kinoshita M, Fujimura M, Kurosawa K, Sakuramachi Y, Takano K, Matsunaga S, Okamura S, Kitatani M, Tsujii S, Hayashino Y, Kurita N; Diabetes Distress, Care Registry at Tenri Study Group. Urinary C-megalin as a novel biomarker of progression to microalbuminuria: a cohort study based on the Diabetes Distress and Care Registry at Tenri (DDCRT 22). Diabetes Res Clin Pract. 2022 Mar 2;109810.
2. Koiwa F, Yazawa R, Fukagawa M, Honda D, Akizawa T. First-in-Human Phase I Study of the Novel Injectable Calcimimetic Agent Upacicalcet in Healthy Adult Japanese Participants. Drugs R D. 2022 Mar 25
3. Nishiwaki H, Abe Y, Hasegawa T, Levack WMM, Noma H, Ota E. Erythropoiesis‐stimulating agents for preventing acute kidney injury (protocol). Cochrane Database of Systematic Reviews 2022, Issue 5. Art. No.: CD014820.
4. Kazama JJ, Koiwa F, Yokoyama K, Fukagawa M, Asano K, Honda D, Akizawa T. First-in-Patient Phase I/II Study of Upacicalcet in Japanese Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis: Pharmacokinetic and Pharmacodynamic Properties. Clin Pharmacokinet. 2022 Sep;61(9):1271-1284.
5. Yajima N, Kawaguchi T, Takahashi R, Nishiwaki H, Toyoshima Y, Oh K, Odai T, Kanai T, Morisky DE, Yamaguchi T, Kasama T. Adherence to methotrexate and associated factors considering social desirability in patients with rheumatoid arthritis: a multicenter cross-sectional study. BMC Rheumatology 2022 (in press)
6. Sasai F, Rogers KL, Orlicky DJ, Stem A, Schaeffer J, Garcia G, Fox J, Ray MS, Butler-Dawson J, Gonzalez-Quiroz M, Leiva R, Taduri G, Anutrakululchai S, Venugopal V, Madero M, Glaser J, Wijkstrom J, Wernerson A, Brown JM, Johnson RJ, Roncal-Jimenez CA. Inhaled silica nanoparticles cause chronic kidney disease in rats. Am J Physiol Renal Physiol. 2022 Jul 1;323(1):F48-F58

2021年

1. Hasegawa T, Nishiwaki H, Ota E, Levack WMM, Noma H. Aldosterone antagonists for people with chronic kidney disease requiring dialysis. Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD013109.
2. Nishiwaki H*, Niihata K*, Shimizu S, Shibagaki Y, Yamamoto R, Nitta K, Tsukamoto T, Uchida S, Takeda A, Okada H, Narita I, Isaka Y, Kurita N, and Japan Nephrotic Syndrome Cohort Study group. (*equally contributed). Incidence and factors associated with prescribing renin-angiotensin-system inhibitors in adult idiopathic nephrotic syndrome: a nationwide cohort study. J Clin Hypertension. 2021[in press]
3. Komatsuzaki Y, Ikeda M, Shimizu A, Matsuo N, Maruyama Y, Yokoo T, Yamamoto H, Joki N, Ando R, Inaguma D, Yamaka T, Nakayama M, Koiwa F, Kawamoto S, Negi S, Shigematsu T. False-negative diagnosis of high anion gap in patients with end-stage kidney disease. Sci Rep. 2021 Feb 25;11(1):4600
4. Isaka Y, Hamano T, Fujii H, Tsujimoto Y, Koiwa F, Sakaguchi Y, Tanaka R, Tomiyama N, Tatsugami F, Teramukai S. Optimal Phosphate Control Related to Coronary Artery Calcification in Dialysis Patients. J Am Soc Nephrol. 2021 Mar;32(3):723-735
5. Sato Y, Tsukaguchi H, Higasa K, Kawata N, Inui K, Linh TNT, Quynh TTH, Yoshihiko I, Koiwa F, Yoshimura A. Positive renal familial history in IgA nephropathy is associated with worse renal outcomes: a single-center longitudinal study. BMC Nephrol. 2021 Jun 19;22(1):230.
6. Gomi K, Ito T, Yamaguchi F, Kamio Y, Sato Y, Mori H, Endo K, Abe T, Sakakura S, Kobayashi K, Shimada K, Noda J, Hibiki T, Ohta S, Sagara H, Tanaka A, Jinno M, Yamawaki M, Nishimoto F, Inoue K, Nagahama M. Clinical features and mechanism of liver injury in patients with mild or moderate coronavirus disease 2019. JGH Open 2021 [in press]
7. Koiwa F, Tokunaga S, Endo Y, Fukagawa M, Akizawa T. Efficacy of Evocalcet in Previously Cinacalcet-Treated Secondary Hyperparathyroidism Patients. Kidney Int Rep 6: 2830-2839, 2021
8. Shikida Y, Mizobuchi M, Yoshitake O, Kato T, Ogata H, Koiwa F, Honda H. Lower soluble Klotho levels in the pretransplant period are associated with an increased risk of renal function decline in renal transplant patients. Ther Apher Dial. 2021 Jun;25(3):331-340.

2020年

1. Sasaki S, Takada T, Fukuma S, Imamoto M, Hasegawa T, Nishiwaki H, Iida H, Fukuhara S. Screening tool for identifying adults with excessive salt intake among community-dwelling adults: a population-based cohort study. Am J Clin Nutr. 2020 Apr 1;111(4):814-820.
2. Mizobuchi M, Ogata H, Koiwa F, Honda H. Early response of the parathyroid gland to withdrawal of a calcimimetic compound in uremic rats. Am J Physiol Renal Physiol. 2020 Mar 1;318(3):F639-F646
3. Toshiaki Usui, Naoki Morito, Yoshinori Sato, Hiroyasu Tsukaguchi, Michito Hamada, Hyojung Jeon, Manoj Kumar Yadav, Akihiro Kuno, Yuki Tsunakawa, Risa Okada, Takaaki Ojima, Maho Kanai, Keigo Asano, Yuki Imamura, Ryusuke Koshida, Keigyou Yoh, Joichi Usui, Hideki Yokoi, Masato Kasahara, Ashio Yoshimura, Masafumi Muratani, Takashi Kudo, Hisashi Oishi, Kunihiro Yamagata, Satoru Takahashi. Transcription factor MafB in podocytes protects against the development of focal segmental glomerulosclerosis. kidney Int 2020 Aug;98(2):391-403.
4. Kawata N, Kang D, Aiuchi T, Obama T, Yoshitake O, Shibata T, Takimoto M, Itabe H, Honda K. Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry. Nephrology (Carlton). 2020 Apr;25(4):351-359

2019年

1. Hasegawa T, Sakamaki K, Koiwa F, Akizawa T, Hishida A Clinical Prediction Models for Progression of Chronic Kidney Disease to End-Stage Kidney Failure under Pre-dialysis Nephrology Care: Results from the Chronic Kidney Disease Japan Cohort Study.Clin Exp Nephrol. 2019; 23 (2): 189-198.
2. Maruta Y, Hasegawa T, Yamakoshi E, Nishiwaki H, Koiwa F, Imai E, Hishida A. Association between Serum Na-Cl Level and Renal Function Decline in Chronic Kidney Disease: Results from the Chronic Kidney Disease Japan Cohort (CKD-JAC) Study. Clin Exp Nephrol. 2019; 23 (2): 215-222
3. Nishiwaki H, Hasegawa T, Koiwa F, Hamano T, Masakane I. The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. PLoS One. 2019 Jan 10;14(1):e0210533
4. Tanaka M , Nishiwaki H, Kado H, Doi Y, Ihoriya C ,Omae K , Tamagaki K. Impact of salt taste dysfunction on interdialytic weight gain for hemodialysis patients: a cross-sectional study. BMC Nephrol 2019 Apr 5;20(1):121..
5. Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment. Clin Kidney J. 2018 Sep 19;12(2):294-299.
6. Nishiwaki H, Sasaki S, Hasegawa T, Sasai F, Kawarazaki H, Minatoguchi S, Uchida D, Koitabashi K, Ozeki T, Koiwa F, and the JOINT-KD collaborators. External validation of the quick Sequential Organ Failure Assessment score for mortality and bacteremia risk evaluation in Japanese patients undergoing hemodialysis: A retrospective multi-center cohort study. BMJ open. 2019 Jul 11;9(7):e028856.
   
7. Iida H, Kurita N, Takahashi S, Sasaki S, Nishiwaki H, Omae K, Yajima N, Fukuma S, Hasegawa T, Fukuhara S and The Sukagawa Study Group. Salt intake and body weight correlate with higher blood pressure in the very elderly population: The Sukagawa study. J Clin Hypertens. 2019;00:1–8
8. Niihata K, Nishiwaki H, Kurita N, Okada H, Maruyama S, Narita I, Shibagaki Y, Nakaya I. Variations in actual practice patterns and their deviations from the clinical practice guidelines for nephrotic syndrome in Japan: certified nephrologists’ questionnaire survey.Clin Exp Nephrol. 2019;23(11):1288-1297.
9. Miyazaki T, Gharib SA, Hsu YA, Xu K, Khodakivskyi P, Kobayashi A, Paragas J, Klose AD, Francis KP, Dubikovskaya E, Page-McCaw PS, Barasch J, Paragas N. Cell-specific image-guided transcriptomics identifies complex injuries caused by ischemic acute kidney injury in mice. Commun Biol. 2019 Sep 2;2:326
10. Kawata N, Kang D, Aiuchi T, Obama T, Yoshitake O, Shibata T, Takimoto M, Itabe H, Honda K. Proteomics of human glomerulonephritis by laser microdissection and liquid chromatography-tandem mass spectrometry. Nephrology (Carlton). 2019 Nov 9. [Epub ahead of print]
11. Takahashi G, Honda H, Takahashi K, Ikeda M, Hosaka N, Ogata H, Koiwa F, Shishido K, Shibata T. Truncal Adiposity Influences High-Density Lipoprotein Cholesterol Levels and Cardiovascular Events in Hemodialysis Patients. J Ren Nutr. 2019 May;29(3):235-242
12. Hayashi T, Tanaka Y, Iwasaki M, Hase H, Yamamoto H, Komatsu Y, Ando R, Ikeda M, Inaguma D, Sakaguchi T, Shinoda T, Koiwa F, Negi S, Yamaka T, Shigematsu T, Joki N. Association of Circulatory Iron Deficiency With an Enlarged Heart in Patients With End-Stage Kidney Disease. J Ren Nutr. 2019 Jan;29(1):39-47

2018年

1. Sato Y, Tsukaguchi H, Morita H, Higasa K, Tran MTN, Hamada M, Usui T, Morito N, Horita S, Hayashi T, Takagi J, Yamaguchi I, Nguyen HT, Harada M, Inui K, Maruta Y, Inoue Y, Koiwa F, Sato H, Matsuda F, Ayabe S, Mizuno S, Sugiyama F, Takahashi S, Yoshimura A. A mutation in transcription factor MAFB causes Focal Segmental Glomerulosclerosis with Duane Retraction Syndrome. Kidney Int. 2018 ; Aug;94(2):396-407
2. Nishiwaki H, Fukuma S, Hasegawa T, Kimachi K, Akizawa T, Fukuhara S. Dialysis-related practice patterns among hemodialysis patients with cancer. Health Science Reports. 2018 [In press]
3. Nishiwaki H, Hasegawa T, Shinji M, Matsuo F, Watanabe T, Makino H, Koiwa F, Hishida A. Practice pattern of physician’s directions of exercise restriction in patients with chronic kidney disease: results from the Chronic Kidney Disease Japan Cohort study. Clin Exp Nephrol. 2018 ;Mar 19.[Epub ahead of print]
4. Kovesdy CP, Matsushita K, Sang Y, Brunskill NJ, Carrero JJ, Chodick G, Hasegawa T, Heerspink HL, Hirayama A, Landman GWD, Levin A, Nitsch D, Wheeler DC, Coresh J, Hallan SI, Shalev V, Grams ME. Serum Potassium and the Risk of Adverse Outcomes Across the Range of Kidney Function: A CKD Prognosis Consortium Meta-Analysis. Eur Heart J. 2018 May 1;39(17):1535-1542
5. Hoshino J, Hamano T, Abe M, Hasegawa T, Wada A, Ubara Y, Takaichi K, Inaba M, Nakai S, Masakane I. Superiority of glycated albumin over hemoglobin A1c in predicting mortality in diabetic hemodialysis patients. Nephrol Dial Transplant. [Epub ahead of print]
6. Niihata K, Takahashi S, Kurita N, Yajima N, Omae K, Fukuma S, Okano T, Nomoto Y, Omori K, Fukuhara S; Sukagawa Study Group* (*collaborators: Hasegawa T, Iida H, Kobayashi S, Sasaki S, Naganuma T, Nishiwaki H, Tominaga R). Association Between Accumulation of Advanced Glycation End-Products and Hearing Impairment in Community-Dwelling Older People: A Cross-Sectional Sukagawa Study. J Am Med Dir Assoc. 2018;19(3):235-239.
7. Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients. Kidney Int Rep. 2018 3(1):185-192.
8. Minatoguchi S, Nomura A, Imaizumi T, Sasaki S, Ozeki T, Uchida D, Kawarazaki H, Sasai F, Tomita K, Shimizu H, Fujita Y. Low serum albumin as a risk factor for infection-related in-hospital death among hemodialysis patients hospitalized on suspicion of infectious disease: a Japanese multicenter retrospective cohort study. Renal Replacement Therapy 2018; 4: 30
9. Hasegawa T, Nishiwaki H, Ota E, William MM Levack, Noma H. Aldosterone antagonists for people with chronic kidney disease requiring dialysis (protocol). Cochrane Database of Systematic Reviews.[in press]
10. Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients. Kidney Int Rep. 2018 3 (1): 185-192
11. Hayashi T, Tanaka Y, Iwasaki M, Hase H, Yamamoto H, Komatsu Y, Ando R, Ikeda M, Inaguma D, Sakaguchi T, Shinoda T, Koiwa F, Negi S, Yamaka T, Shigematsu T, Joki N. Association of Circulatory Iron Deficiency With an Enlarged Heart in Patients With End-Stage Kidney Disease. J Ren Nutr. 2018 Aug 7
12. Koiwa F; Yokoyama Y; Fukagawa M; Akizawa T. Evaluation of changes in ferritin levels during sucroferric oxyhydroxide treatment. Clin Kidney J Sep 19, 2018

2017年

1. Nishiwaki H, Hasegawa T, Ikenoue T, Tominaga N, Yazawa M, Kawarazaki H, Shibagaki Y, Yamamoto Y, Fukuma S, Yamazaki S, Fukuhara S. Association between post-dialysis hemoglobin level and the survival of vascular access. J Vasc Access 2017. [Epub ahead of print]
2. Hasegawa T, Zhao J, Duller DS, Bieber B, Zee J, Morgenstern H, Hanafusa N, Nangaku M. Erythropoietin hyporesponsiveness in dialysis patients: possible role of statins. Am J Nephrol. 2017;46(1):11-17.
3. Imaizumi T, Hasegawa T, Nomura T, Sasaki S, Nishiwaki H, Ozeki T, Shimizu H, Minatoguchi S, Yamakawa T, Yazawa M, Uchida D, Kawarazaki H, Miyamoto M, Suzuki T, Koitabashi K, Furusho M, Fujita Y. Association between Staphylococcus aureus bacteremia and hospital mortality in hemodialysis patients with bloodstream infection: a multicenter cohort from Japanese tertiary care centers. Ther Apher Dial. [Epub ahead of print]
4. Sasaki S, Hasegawa T, Kawarazaki H, Nomura A, Uchida D, Imaizumi T, Furusho M, Nishiwaki H, Fukuma S, Shibagaki Y, Fukuhara S. Development and Validation of a Clinical Prediction Rule for Bacteremia among Maintenance Hemodialysis Patients in Outpatient Settings. PLoS ONE. 2017;12(1): e0169975.
5. Sasaki S, Kawarazaki H, Hasegawa T, Shima H, Naganuma T, Shibagaki Y. Anemia and Long-Term Renal Prognosis in Patients with Post-Renal Acute Kidney Injury of Nonmalignant Cause. Nephron. 2017;135(2):129-136.
6. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Annual peritoneal dialysis report 2014, the peritoneal dialysis registry. Renal Replacement Therapy. 2017; 3: 21.
7. Nitta K, Masakane I, Tomo T, Tsuchida K, Ikeda K, Ogawa T, Kanda E, Kanno Y, Komatsu Y, Taniguchi M, Taki F, Hasegawa T, Hanafusa N, Hamano T, Fukagawa M, Minakuchi J, Yamamoto H, Washida N, Wada T, Watanabe Y. Policy for developing clinical practice guidelines of Japanese Society for Dialysis Therapy. Renal Replacement Therapy. 2017; 3: 34.
8. Uchida D, Sasaki S, Kawarazaki H, Miyamoto M, Nomura A, Koitabashi K, Nishiwaki H, Shibagaki Y; Japanese InvestigatOrs with Innovative NeTwork about Kidney Disease (JOINT-KD). Systemic Inflammatory Response Syndrome Is Not an Indicator of Bacteremia in Hemodialysis Patients With Native Accesses: A Multicenter Study. ASAIO J. 2017; 63:501-506.
9. Perl J, Karaboyas A, Morgenstern H, Sen A, Rayner H, Vanholder R, Combe C, Hasegawa T, Finkelstein F, Lopes A, Robinson BM, Pisoni RL, Tentori F. Association between Changes in Quality of Life and Mortality in Hemodialysis Patients: Results from the DOPPS. Nephrol Dial Transplant. 2017;32(3):521-527.
10. Koiwa F, Terada A. Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo- controlled, double-blind, Phase II study. Clin Exp Nephro. 2017; 21: 513-522.
11. Koiwa F, Yokoyama K, Fukagawa M, Terao A, Akizawa T. Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomised, open-label, multicentre, 12-week Phase III study. Nephrology. 2017; 22: 293-300.
12. Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Long-term assessment of the safety and efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese hemodialysis patients with hyperphosphatemia: An open-label, multicenter, phase III study. J Ren Nutr. [Epub ahead of print]
13. Koiwa F, Yokoyama K, Fukagawa M, Akizawa T. Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients. Kidney Int Rep. 2017 Oct 6;3(1):185-192.
14. Ikeda M, Ueda Y, Maruyama Y, Yokoyama K, Yokoo T, Joki N, Ando R, Shinoda T, Inaguma D, Yamaka T, Komatsu Y, Koiwa F, Sakaguchi T, Negi S, Shigematsu T. Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease. Clin Exp Nephrol. 2017 Oct;21(5):825-834.
15. Nagayama Y, Inoue Y, Inui K, Yoshimura A: Comparison of Renal Outcome among Japanese Patients with or without Microangiopathic Hemolysis in Malignant Phase Hypertension: A Single-Center Retrospective Study. Nephron. 2017; 137(3): 197-204.
16. Rayner H, Larkina M, Wang Graham-Brown MM, van der Veer SN, Ecder T, Hasegawa T, Kleophas W, Bieber B, Tentori F, Robinson, Pisoni RL. International comparisons of prevalence, awareness and treatment of pruritus in people on hemodialysis. Clin J Am Soc Nephrol. 2017. [Epub ahead of print]
17. Andriotti T, Stavale R, Nafee T, Fakhry S, Mohamed MMA, Sofiyeva N, Ganho-Ávila A, Bogner A, Barbosa SP, Piton LS, Hirayama ALS, Gaccia G, Smith-Howard Junior TP, Miranda PC, Reyes KJC, Gragera A, Nishiwaki H, Boechat-Barros R.  ASSERT trial – How to assess the safety and efficacy of a high frequency rTMS in postpartum depression ? A multicenter, double blinded, randomized, placebo-controlled clinical trial. Contemp Clin Trials Commun. 2017 Jan 13;5:86-91.
18. Tan T, Morita H, Inui K, Koiwa F, Inoue Y, Yoshimura A. Ultrastructural Aspects of Rat Renal Tubular Epithelium in Vitro: Scanning Electron Microscopy (SEM) Analyses at Various Stage of Culture. The Showa Univ. J. Med. Sci.   2017；Sep; 29(3): 307-314

2016年

1. Masakane I, Hasegawa T, Ogata S, Kimata N, Nakai S, Hanafusa N, Hamano T, Wakai K, Wada A, Nitta K. Peritoneal Dialysis Registry with 2013 Survey Report. Ther Apher Dial. 2016;20(6):557-568.
2. Yazawa M, Kido R, Seiji O, Hasegawa T, Hanafusa N, Iseki K, Tsubakihara Y, Shibagaki Y. Early mortality was high and strongly associated with functional status in incident Japanese hemodialysis patients: A cohort study of the large national dialysis registry. PLoS ONE. 2016;11(6): e0156951.
3. Sakao Y, Ojima T, Yasuda H, Hashimoto S, Hasegawa T, Iseki K, Tsubakihara Y, Kato A. Serum creatinine modifies associations between body mass index and mortality and morbidity in prevalent hemodialysis patients. PLoS ONE. 2016;11(3): e0150003.
4. Akizawa T, Kurita N, Mizobuchi M, Fukagawa M, Onishi Y, Yamaguchi T, Ellis A, Fukuma S, Brookhart A, Hasegawa T, Kurokawa K, Fukuhara S. PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism. Scientific Reports. 2016; 6: 19612.
5. Komukai D, Hasegawa T, Kaneshima N, Takayasu M, Sato Y, Hirose M, Yoshimura T. Influence of Acute Kidney Injury on the Time to Complete Remission in Adult Minimal Change Nephrotic Syndrome: A Single-Center Study. Nephrology. 2016;21(10):887-892.
6. Mizobuchi M, Ogata H, Yamazaki-Nakazawa A, Hosaka N, Kondo F, Koiwa F, Kinugasa E, Shibata T. Cardiac effect of vitamin D receptor modulators in uremic rats. J Steroid Biochem Mol Biol 2016;163: 20-27.
7. Ikeda M, Ueda Y, Maruyama Y, Yokoyama K, Yokoo T, Joki N, Ando R, Shinoda T, Inaguma D, Yamaka T, Komatsu Y, Koiwa F, Sakaguchi T, Negi S, Shigematsu T. Possible prevention of uremic nausea by vitamin D receptor activators in non-dialysis patients with stage 5 chronic kidney disease. Clin Exp Nephrol. 2016 [Epub ahead of print]
8. Asakawa T, Komatsu Y, Ando R, Joki N, Tanaka Y, Iwasaki M, Hase M, Ikeda M, Inaguma D, Sakaguchi T, Shinoda T, Koiwa F, Negi S, Yamaka T, Shigematsu T. Effect of long acting erythropoiesis stimulating agents on hemoglobin levels at the initiation of dialysis. Renal Replacement Therapy. 2016; 2: 12.